Notice of Final Results

RNS Number : 7461Z

Instem plc

12 March 2013

 



12 March 2013

Instem plc

("Instem", or the "Company")

Notice of Final Results

Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, will be announcing its unaudited final results for the year ended 31 December 2012 on Wednesday 27 March 2013.

Management will be hosting a presentation for analysts on the day of results at 11am at the offices of Newgate Threadneedle: 5th Floor, 33 King William Street, London, EC4R 9AS.

Analysts who wish to attend the presentation should register their interest with Fiona Conroy, contactable at [e-mail] or 020 7653 9847.

For further information, please contact:

Instem plc	[phone]
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser & Broker)	[phone]
Aubrey Powell
Joe Stroud
Newgate Threadneedle	[phone]
Caroline Evans-Jones
Fiona Conroy

About Instem plc

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports its clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com.

 

END

 

 

NORSFFFWFFDSELD